Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.8.3731

Korean Epithelial Ovarian Cancer Study (Ko-EVE): Protocols and Interim Report  

Ma, Seung Hyun (Department of Preventive Medicine, College of Medicine, Seoul National University Hospital, Seoul National University)
Kim, Byoung-Gie (Department of Obstetrics and Gynecology, Samsung Medical Center & Sungkyunkwan University School of Medicine)
Choi, Ji-Yeob (Department of Biomedical Science, Seoul National University Hospital, Seoul National University)
Kim, Tae-Joong (Department of Obstetrics and Gynecology, Samsung Medical Center & Sungkyunkwan University School of Medicine)
Kim, Yong-Man (Department of Obstetrics and Gynecology, College of Medicine, University of Ulsan, Asan Medical Center)
Kim, Jae Weon (Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul National University)
Kang, Sokbom (Department of Gynecologic Oncology, National Cancer Center)
Kang, Daehee (Department of Preventive Medicine, College of Medicine, Seoul National University Hospital, Seoul National University)
Yoo, Keun-Young (Department of Preventive Medicine, College of Medicine, Seoul National University Hospital, Seoul National University)
Park, Sue K. (Department of Preventive Medicine, College of Medicine, Seoul National University Hospital, Seoul National University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.8, 2012 , pp. 3731-3740 More about this Journal
Abstract
Background: There have been few studies of Asian ovarian cancer and benign tumors. The primary aim of this paper was to report the protocol of the Ko-EVE study to examine epidemiological and molecular factors for ovarian cancer and benign neoplasms and to ascertain the major risk factors for ovarian cancer control in Korea. Methods: This case-control study covers incident epithelial ovarian cancers and benign neoplasms, four major centers participating in enrolling incident cases and 3 hospitals enrolling healthy controls among health examinees. Standardized questionnaires were administered by trained interviewers, including sections on socio-demographics characteristics, past medical history, medication usage, family history, lifetime consumption of alcohol and tobacco, diet, physical activity, and reproductive factors for women. Various biological specimens were collected in the biorepository according to the standardized protocol. Annual follow-up for cancer cases and follow-up at the 1st year for benign tumor cases are performing to evaluate treatment effect and progression. Passive follow to see long-term survival will be conducting using record linkage with national data. Results: The total number recruited in 2010-2011 was 246 epithelial ovarian cancer cases, 362 benign epithelial tumors and 345 controls. We are planning to collect subjects for at least 1,500 sets of ovarian cancer, 2,000 benign tumors and 1,500 controls till 2018. Conclusions: The Ko-EVE will provide unique and important data to probe the etiology and natural history of Korean epithelial ovarian cancer. It will be continued by genomic and proteomic epidemiological analyses and future intervention studies for the prevention of ovarian cancer among Koreans.
Keywords
Ovarian cancer; protocol; Ko-EVE study; case; control study;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Ahn Y, Kwon E, Shim JE, et al (2007). Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr, 61, 1435-41.   DOI   ScienceOn
2 Aktas D, Guney I, Alikasifoglu M, et al (2002). CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol, 86, 124-8.   DOI   ScienceOn
3 Bertone E R, Rosner B A, Hunter D J, Stampfer M J, Speizer F E, et al (2002). Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol, 156, 22-31.   DOI
4 Chang Y M, Tai CF, Yang S C, et al (2003). A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan. Ann Epidemiol, 13, 652-660.   DOI
5 Chen Y, Wu PC, Lang JH, et al (1992). Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol, 21, 23-29.   DOI
6 Chiu H F, Chang CC, Yang C Y (2004). Magnesium and calcium in drinking water and risk of death from ovarian cancer. Magnesium Res, 17, 28-34.
7 Cho LY, Kim CS, Li L, Yang J J, Park B, et al (2009). Validation of self-reported cancer incidence at follow-up in a prospective cohort study. Ann Epidemiol, 19, 644-6.   DOI
8 Ferlay J, Shin H R, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-2917.   DOI
9 Fujita M, Tase T, Kakugawa Y, et al (2008). Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study. Tohoku J Exp Med, 216, 297-307.   DOI
10 Han S, Lee K M, Choi J Y, Park S K, Lee J Y, et al (2008). CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat, 110, 387-93.   DOI
11 Hirose K, Tajima K, Hamajima N, Kuroishi T, Kuzuya K, et al (1999). Comparative case referent study of risk factors among hormone-related female cancers in Japan. Cancer Science, 90, 255-61.   DOI
12 Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Internal Med, 166, 1871.   DOI
13 Jeong N H, Song E S, Lee J M, Lee K B, Kim M K, et al (2009). Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand, 88, 457-62.   DOI
14 Jordan S, Green A and Webb P (2006). Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control, 17, 623-632.   DOI
15 Kang S, Duan L H, Li Y, et al (2004). Relation between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer. Zhonghua Fu Chan Ke Za Zhi, 39, 556-7 (in Chinese).
16 Kobayashi H, Sumimoto K, Moniwa N, et al (2007). Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer, 17, 37-43.   DOI
17 Kato I, Tominaga S and Terao C (1989). Alcohol consumption and cancers of hormone-related organs in females. Jpn J Clin Oncol, 19, 202-207.
18 Kim MK, Kim K, Kim SM, et al (2009). A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol, 20, 238-242.   DOI   ScienceOn
19 Kim YM, Whang DH, Park J, et al (2011). Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Clin Chem Lab Med, 49, 527-534.
20 Kolahdooz F, van der Pols JC, Bain CJ, et al (2010). Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and metaanalysis. Am J Clin Nutr, 91, 1752-63.   DOI
21 Lalwani N, Prasad S R, Vikram R, et al (2011). Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics, 31, 625-46.   DOI
22 Larsson SC, Wolk A (2005). No association of meat, fish, and egg consumption with ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 1024-5.   DOI
23 Lee JY, Park A K, Lee KM, et al (2009). Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. Carcinogenesis, 30, 1528-31.   DOI
24 Lee KM, Park SK, Hamajima N, et al (2005). Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat, 90, 149-55.   DOI
25 Lin HW, Tu YY, Lin SY, et al (2011). Risk of ovarian cancer in women with pelvic inflammatory disease: a populationbased study. Lancet Oncol, 12, 900-4.   DOI
26 Li Y, Jin X, Kang S, et al (2006). Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol, 101, 92-6.   DOI
27 Li Y, Liang J, Kang S, et al (2008). E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Gynecol Oncol, 108, 409-14.   DOI
28 Li Y, Wang Y, Kang S, et al (2010). Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. Int J Gynecol Cancer, 20, 717-23.   DOI
29 Liu FYC (2010). Association between CYP1A1 Ile/Val polymorphisms and ovarian cancer risk. J Hebei North Univ (Med Ed), 27, 29-30.
30 Lynch H T, Casey M J, Snyder C L, et al (2009). Hereditary ovarian cancer: Molecular genetics, pathology, management, and heterogeneity. Molecular Oncology, 3, 97.   DOI   ScienceOn
31 Ma X, Zhang J, Liu S, et al (2011). Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. Gynecol Oncol, 122, 554-559.   DOI
32 Ministry of Health & Welfare KCfDCaP (2009). Korea National Health & Nutrition Examination Survey., from Available from: http://knhanes.cdc.go.kr/.
33 Ministry of Health and Welfare (2012). National Cancer Information Center from Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html#4. .
34 Mori M, Harabuchi I, Miyake H, et al (1988). Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol, 128, 771-777.   DOI
35 Niwa Y, Wakai K, Suzuki S, et al (2005). Cigarette smoking and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort study. J Obstet Gynaecol Res, 31, 144-51.   DOI
36 Mori M, Kiyosawa H, Miyake H (1984). Case-control study of ovarian cancer in Japan. Cancer, 53, 2746-52.   DOI
37 Mori M, Nishida T, Sugiyama T, et al (1998). Anthropometric and other risk factors for ovarian cancer in a case-control study. Jpn J Cancer Res, 89, 246-53.   DOI
38 Nandakumar A, Anantha N, Dhar M, Ahuja V, Kumar R, et al (1995). A case control investigation on cancer of the ovary in Bangalore, India. Int J Cancer, 63, 361-5.   DOI
39 Niwa Y, Yatsuya H, Tamakoshi K, et al (2005). Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. J Obstet Gynaecol Res, 31, 452-8.   DOI   ScienceOn
40 Office KNS (2009). The pilot result of birth statistics in 2009 from Available from: http://kostat.go.kr/.
41 Pan SY, Ugnat AM, Mao Y, et al (2004). A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 13, 1521-1527.
42 Park B, Kim TJ, Ma SH, et al (2010). Epidemiological characteristics of ovarian cancer in Korea. J Gynecologic Oncol, 21, 241.   DOI
43 Park J, Hilmers DC, Mendoza JA, et al (2010). Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea. J Korean Med Sci, 25, 75-82.   DOI
44 Sakauchi F, Khan M M, Mori M, et al (2007). Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer, 57, 138-145.   DOI
45 Park SK, Yoo KY, Lee SJ, et al (2000). Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics, 10, 301-309.   DOI   ScienceOn
46 Park YS, Lee DH, Choi JM, et al (2004). Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatrics, 47, 247-57.   과학기술학회마을
47 Qie M, Zhang Y, Wu J (2002). Study on the relationship between cervical cancer and p53 codon 72 polymorphism. J West China Univ Med Sci, 33, 274 (in Chinese).
48 Schulz M, Nothlings U, Allen N, et al (2007). No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 16, 852-5.   DOI
49 Shu XO, Gao YT, Yuan JM, et al (1989). Dietary factors and epithelial ovarian cancer. Br J Cancer, 59, 92-96.   DOI
50 Sokal D C, Vach T H, Nanda K, et al (2010). Quinacrine sterilization and gynecologic cancers: A case-control study in northern Vietnam. Epidemiology, 21, 164.
51 Sugawara T, Nomura E, Sagawa T, et al (2003). CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer, 13, 785-790.   DOI
52 Ueda M, Terai Y, Kanda K, et al (2006). Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol, 100, 173-8.   DOI
53 Wernli KJ, Ray RM, Gao DL, et al (2008). Occupational exposures and ovarian cancer in textile workers. Epidemiology, 19, 244-50.   DOI
54 Yang XY, Yu H, Xi MR, et al (2009). Association of the ARLTS1 variants with familial ovarian cancer risk in China. Int J Gynecol Cancer, 19, 585-90.   DOI
55 Woong-Shick A, Sung-Pil P, Su-Mi B, et al (2005). Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci, 96, 197-201.   DOI   ScienceOn
56 Xie X, Ye D, Chen H, et al (2004). Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma. Int J Gynecol Obstets, 85, 151-8.   DOI
57 Yang C, Chan K, Ngan H, et al (2006). Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis, 27, 1502.   DOI
58 Yen M L, Yen B L, Bai C H, et al (2003). Risk factors for ovarian cancer in Taiwan: a case-control study in a lowincidence population. Gynecol Oncol, 89, 318-324.   DOI   ScienceOn
59 Yun T K, Choi S Y (1995). Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiology Biomarkers & Prevention, 4, 401-8.
60 Zhang H, Zhang S, Cui J, et al (2008). Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Aust NZ J Obstets Gynaecol, 48, 505-9.   DOI
61 Zhang M, Binns CW, Lee AH (2002a). Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev, 11, 713-8.
62 Zhang M, Holman CD, Binns C W (2007). Intake of specific carotenoids and the risk of epithelial ovarian cancer. Br J Nutr, 98, 187-93.   DOI
63 Zhang M, Xie X, Lee AH, Binns CW (2004b). Prolonged lactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev, 13, 499-502.   DOI   ScienceOn
64 Zhang M, Lee A H, Binns CW (2003). Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer, 105, 838-43.   DOI   ScienceOn
65 Zhang M, Lee AH, Binns CW (2004a). Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol, 92, 320-6.   DOI   ScienceOn
66 Zhang M, Xie X, Holman CD (2005). Body weight and body mass index and ovarian cancer risk: a case-control study in China. Gynecol Oncol, 98, 228-34.   DOI
67 Zhang M, Xie X, Lee A H, et al (2004c). Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes and Control, 15, 83-89.   DOI   ScienceOn
68 Zhang M, Xie X, Lee A H, et al (2004d). Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer, 49, 125-130.   DOI
69 Zhang M, Yang Z Y, Binns C, et al (2002b). Diet and ovarian cancer risk: a case-control study in China. Br J Cancer, 86, 712-717.   DOI
70 Zhang Z, Zhou B, Zhang J, et al (2010). Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer. Cancer Genet Cytogenet, 196, 146-152.   DOI
71 Zhen H, Yang S, Wu H, et al (2010). LyGDI is a promising biomarker for ovarian cancer. Int J Gynecol Cancer, 20, 316-322.   DOI
72 Zou L, He X, Zhang JW (2010). The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res, 43, 1232-1238.   DOI
73 Zy Z, Yq M, Xm F, et al (2010). Relationship between CYP1A1 gene polymorphism and susceptibility of ovarian cancer. Chin J Cancer Prev Treat, 17, 1325-7.